APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $995,359 | -0.6% | 10,926 | -28.1% | 0.00% | 0.0% |
| Q1 2023 | $1,001,866 | +12.7% | 15,189 | -11.6% | 0.00% | 0.0% |
| Q4 2022 | $888,947 | +54.9% | 17,191 | +104.7% | 0.00% | +100.0% |
| Q3 2022 | $574,000 | +52.7% | 8,399 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $376,000 | -72.1% | 8,307 | -79.7% | 0.00% | -66.7% |
| Q3 2021 | $1,350,000 | +375.4% | 40,966 | +812.8% | 0.00% | – |
| Q2 2021 | $284,000 | +26.2% | 4,488 | +13.9% | 0.00% | – |
| Q4 2020 | $225,000 | -53.0% | 3,941 | -75.2% | 0.00% | -100.0% |
| Q3 2020 | $479,000 | -45.5% | 15,869 | -41.0% | 0.00% | 0.0% |
| Q2 2020 | $879,000 | -4.1% | 26,913 | -21.3% | 0.00% | -50.0% |
| Q1 2020 | $917,000 | +45.3% | 34,211 | +65.9% | 0.00% | +100.0% |
| Q4 2019 | $631,000 | – | 20,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |